Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00783250Phase 4Terminated
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Salbutamol+Tiotropium with Placebo + Tiotropium (2 arms). Primary endpoint: Recordings of respiratory mechanics at 90 minutes. Started Sep 2008; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00783250.